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a b s t r a c t
Transient mammary gland development and lactation can occur eventually in weanling
foals, yearlings, and adult mares without previous or recent history of pregnancy. The
etiology of this condition has not beenwell documented, and there is limited information
on the occurrence, frequency of episodes, composition, and treatment of galactorrhea
secretion. This article reports a case of Brazilian Sport Horse mare, aged 10 years, with
persistent lactation during 5 months. The treatment consisted of bromocriptine 0.04 mg/
kg, b.i.d., orally, for 10 days, associated with hydrotherapy for 20 minutes, twice daily.
After 20 days of the treatment onset, the mare was reevaluated, and a signiﬁcant
decrease in the volume of the udder and the amount of secretion produced was noted,
and its aspect was clearer (serous) and consisted of more ﬂuid compared with the one
collected before treatment. No other clinical alterations or associated diseases were
identiﬁed. Based on these ﬁndings, we suggest the diagnosis of idiopathic inappropriate
lactation. Although there is no information about pharmacokinetics and description of
the oral bromocriptine use in horses, being a therapeutic option for inappropriate
lactation treatment in mares, it was effective at the recommended dosage.
 2012 Elsevier Inc. All rights reserved.
1. Introduction
Galactorrhea may be deﬁned as secretion of milk or
milk-like secretion that occurs in the absence of parturition
or after weaning. Two conditions may be deﬁned: prema-
ture lactation, when the lactation occurs precociously
during pregnancy, or inappropriate lactation, when lacta-
tion occurs in the absence of gestation [1].
In humans, galactorrhea occurs as a result of increased
plasma levels of prolactin, a hormone secreted by the
adenohypophysis. Hyperprolactinemia is a common
disorder of the hypothalamic-pituitary axis, which usually
presents with reproductive abnormalities [2,3]; it may be
caused by pituitary tumors, hypothyroidism, or secondary
effects of drugs [1,4].
A transient mammary gland development and lactation
can occur [5,6] eventually in weanling foals, yearlings, and
adult mares without previous or recent history of preg-
nancy. The etiology of this condition in these animals has
not beenwell documented [1,6]; additionally, there are few
reports on the occurrence, frequency of episodes, or
composition of the galactorrhea secretion [7].
The most commonly identiﬁed cause of inappropriate
lactation in mares is an elevation in prolactin levels,
secondary to Cushing disease [5,6,8]. In the literature, two
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mares were reported having these clinical signs [9]. Thus,
this report aims to describe galactorrhea in an animal
without clinical signs of Cushing disease and proposes
a new treatment option with the use of bromocriptine.
2. Case Report
A Brazilian Sport Horse mare, aged 10 years and
weighing 570 kg, kept in a stable and fed coast cross hay
and commercial concentrate (12% crude protein [CP]), was
presented at the Veterinary Hospital of the College of
Veterinary Medicine of the University of São Paulo, São
Paulo, Brazil, with a 5-month history of persistent lactation,
associated with discomfort caused by the swelling of the
udder and spontaneous ejection of milk (Fig. 1).
Themarewas nulliparous, and it was never inseminated
or given any hormone treatment. The animal had no
contact with foals, and there were no data available from
previous reproductive examinations. Throughout the
period, no drug therapy was performed, and the only
procedure was milking daily, resulting in a total volume of
approximately 1 L of milk per day.
The inspection of the mare revealed a body condition
score equivalent to 5 (scale of 1-6) [10]. There were no
alterations in vital parameters during physical examination.
In gynecological evaluation, the uterus had normal wall
thickness and absence of free ﬂuid, the left ovary had
multiple follicles with diameters smaller than 15 mm, and
the right ovary showed presence of corpus luteum. A ﬁrm
enlargement of the mammary gland was identiﬁed, and
there was no sensibility or hyperthermia. There was
spontaneous secretion and ejection by sphincters on both
teats. The collected secretion had milk-like appearance and
odor.
The treatment started before obtaining the laboratory
tests results. Bromocriptinewas prescribed at a dose of 0.04
mg/kg, b.i.d., orally, for 10 days. Local hydrotherapy was
also recommended for 20minutes, twice daily. Milking was
only allowed in situations where the mare was in extreme
discomfort due to swelling of the mammary gland, without
completely draining the secretion.
Samples of mammary gland secretion of both teats were
sent to the Laboratory of Milk Production, University of São
Paulo, for fat content analyses by the Gerber method, and
CP content by the Kjeldahl method, calculated by multi-
plying the total nitrogen by a factor of 6.38.
Sample of blood plasma was sent to B.E.T. Laboratories
for analyses of cortisol, triiodothyronine (T3), and total and
free thyroxine (T4) levels. The level of prolactin, which
would be interesting for this case, could not be measured
due to an absence of laboratories that perform this analysis
in the country.
Twenty days after treatment onset, the mare was
reevaluated and a signiﬁcant decrease in the volume of the
udder and the amount of secretionproducedwas found, and
its aspect was clearer (serous) and consisted of more ﬂuid
compared with the one collected before treatment.
3. Discussion
The results of the assessment of mammary secretion
were fat content between 0.8% and 0.9% and CP content
between 1.5% and 1.6%. These results are similar to the
values reported for equine milk obtained from Brazilian
breeds animals during the lactation period, in which the
amount of fat ranged from 0.86% to 1.70% and CP content
between 1.48% and 2.40% [11,12].
In hormonal evaluations, the results were 46.0 ng/dL for
cortisol, 1.15 ng/dL for total T3, 16.1 ng/dL for total T4, and
0.55 ng/dL for free T4. The value of free T4 (0.55 ng/dL)
appeared below the normal range considered for the
equine species (1.76 ng/dL until 4 ng/dL) [13-15]. However,
hypothyroidism in horses cannot be diagnosed by a single
measurement of T3 and T4 andmust be based on one of the
thyroid gland stimulation tests [16].
The concentration of circulating iodothyronine can be
inﬂuenced by many factors not related to the thyroid,
including food deprivation [16-18], phenylbutazone
administration [16,19,20], circadian rhythm [14,16], and
dietary composition [16,21,22]. As women [23,24], rats [25],
cows, and sheep [26,27] have a state of relative hypothy-
roidism during lactation, with levels of circulating T3 and
T4 signiﬁcantly lower [28], this condition may explain the
decrease in circulating T4 in the mare of this case report.
Thyroid hormones modulate the secretion of other
hormones that regulate the mammary function and milk
ejection, thus exerting an indirect regulation of the
mammary gland. Hypothyroidism is often associated with
galactorrhea in nonpregnant women, and in female virgin
rats under experimentally induced hypothyroidism, it is
known to be related to mammary development. All these
phenomena are associated with hyperprolactinemia
because of the hypothalamic secretion of thyrotropin-
releasing hormone (TRH) induced by hypothyroidism. In
addition to stimulating the secretion of pituitary thyroid
stimulatinghormone, TRH is apotent stimulator of prolactin
secretion [25,28].
Prolactin is a single chain peptide hormone secreted by
lactotroph cells located in the adenohypophysis [29,30]. It
is essential for all stages of mammary gland development
and regulates the production and secretion of milk,
including protein synthesis, as casein and a-lactalbumin
[1,4,31]. Its secretion is regulated by dopamine, the main
prolactin inhibitor factor produced by hypothalamus [1,31].
The stimulatory signal for prolactin secretion may beFig. 1. Swelling of the udder and spontaneous milk ejection.
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mediated by TRH, vasoactive intestinal peptide, and
prolactin-releasing peptide [30]. The connections between
the hypothalamus and pituitary are critical in maintaining
the physiological secretion of prolactin, and any malfunc-
tion of the pituitary leads to the loss of inhibition by
dopamine and consequent hyperprolactinemia [3,32].
In women, increased prolactin levels present in cases of
pathological hyperprolactinemia result in effects equiva-
lent to those observed during the postpartum period, with
inhibition of gonadotropin-releasing hormone from the
hypothalamus and subsequent inhibition of follicle-
stimulating hormone and luteinizing hormones. This
results in suppressed gonadal function and promotion of
lactation, which explains why hyperprolactinemia is one of
the most common causes of anovulation. In severe cases of
hyperprolactinemia, galactorrhea and abnormal cycles are
often observed, whereas mild cases may be associated with
a short luteal phase, decreased libido, and anovulatory
infertility [30].
In the present study, the reproductive examination of
the mare showed no signs of dysfunction of the repro-
ductive tract. The presence of a corpus luteum indicates
cyclicity. However, because there was no possibility of the
follow-up of two consecutive reproductive cycles, we
cannot exclude that the mare did not have reproductive
disorders.
Hyperprolactinemia, secondary to Cushing disease, was
ruled out by the absence of clinical features of this
syndrome, such as hirsutism, hyperhidrosis, lameness,
lethargy, polyuria, polydipsia, weight loss, or redistribution
of adipose tissue [33]. Regardless of its low sensitivity,
a serum cortisol evaluation was performed in this study,
and the values were considered normal for adult horses
[15].
In approximately 30%-40% of women with hyper-
prolactinemia and galactorrhea, no tumors in the
hypothalamic-pituitary axis were detected. In such cases,
the disease was classiﬁed as idiopathic [30]. Similar to this
statement, we did not identify other clinical alterations or
diseases associated in this mare. Therefore, we propose the
diagnosis of idiopathic inappropriate lactation.
In the literature, there are few reports of therapeutic
options for the treatment of inappropriate lactation in
mares. The drugs mentioned are dopaminergic agonists
used to treat hyperprolactinemia in humans, such as
bromocriptine, cabergoline, and quinagolide [30]. In this
study, we chose oral bromocriptine because of its lower
cost.
Bromocriptine was the ﬁrst dopamine agonist to be
widely used in the treatment of hyperprolactinemia in
humans [32]. This ergot alkaloid is also used for the treat-
ment of prolactinomas or other micro- or macroadenomas
of the pituitary gland, in cases of menstrual disorders, and
in Parkinson disease. In equine medicine, it is used for
treating Cushing disease [34]. The mechanism of action is
by its binding to dopaminergic receptors (D2) on the
surface of the lactotrophic cells in adenohypophysis,
reducing the activity of adenylate cyclase and inhibiting
prolactin secretion [30,32,34].
Bromocriptine is well established as a safe and effective
therapy [30,35,36]. However, its dosage, efﬁcacy, and side
effects are not well deﬁned in the mare [1,37]. There is no
basic information on pharmacokinetics of bromocriptine in
horses, and the use of oral formulation in this species has
not been reported yet [34]. The administration of bromo-
criptine at a dose of 0.08 mg/kg, b.i.d, intramuscularly, in
ponies during the ﬁnal third of gestation period caused
a reduction in plasma levels of prolactin and progesterone
and induced clinical signs similar to those observed in
pregnant mares intoxicated by the fungus Acremonium
coenophialum in fescue pastures [1,37].
Bromocriptine in this case report provided a rapid
remission of clinical signs. However, the milking interrup-
tion may have contributed to the early resolution of this
case, with consequent inhibition of the reﬂex that leads to
the release of oxytocin by the posterior lobe of the pituitary
gland [1,31].
4. Conclusions
In this case, no apparent clinical disorders or associated
diseases were identiﬁed; therefore, we suggest the diag-
nosis of idiopathic inappropriate lactation for the
mentioned animal. The treatment with bromocriptine at
a dose of 0.04 mg/kg, b.i.d, orally, for 10 days, associated
with local hydrotherapy and not milking provided rapid
improvement of clinical signs and resolution of the inap-
propriate lactation, without the occurrence of side effects.
The protocol proposed was effective in the case reported
and can be considered as a therapeutic option for the
treatment of idiopathic inappropriate lactation in mares.
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